BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22079984)

  • 21. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
    J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress.
    Chung ES; Chung YC; Bok E; Baik HH; Park ES; Park JY; Yoon SH; Jin BK
    Brain Res; 2010 Dec; 1363():143-50. PubMed ID: 20858471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise protects against MPTP-induced neurotoxicity in mice.
    Gerecke KM; Jiao Y; Pani A; Pagala V; Smeyne RJ
    Brain Res; 2010 Jun; 1341():72-83. PubMed ID: 20116369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
    Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
    Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
    J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system.
    Binukumar BK; Bal A; Gill KD
    Neuromolecular Med; 2011 Dec; 13(4):251-65. PubMed ID: 21964614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo.
    Choi SH; Joe EH; Kim SU; Jin BK
    J Neurosci; 2003 Jul; 23(13):5877-86. PubMed ID: 12843292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Yokoyama H; Yano R; Kuroiwa H; Tsukada T; Uchida H; Kato H; Kasahara J; Araki T
    Metab Brain Dis; 2010 Jun; 25(2):135-43. PubMed ID: 20424905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice.
    Wang Q; Shin EJ; Nguyen XK; Li Q; Bach JH; Bing G; Kim WK; Kim HC; Hong JS
    J Neuroinflammation; 2012 Jun; 9():124. PubMed ID: 22695044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Cossetti C; D'Adamo P; Zardini E; Andreoni L; Ihekwaba AE; Serra PA; Franciotta D; Martino G; Pluchino S; Marchetti B
    Neurobiol Dis; 2011 Feb; 41(2):508-27. PubMed ID: 21056667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
    Gao HM; Liu B; Zhang W; Hong JS
    FASEB J; 2003 Oct; 17(13):1954-6. PubMed ID: 12897068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.